Steris reports 7.3% revenue growth, but adjusted EPS misses estimates

Steris Corp. (NYSE: STE) reported first-quarter calendar 2026 revenue of $1.59 billion, up 7.3% from a year earlier and in line with Wall Street expectations, while adjusted earnings of $2.83 a share missed consensus estimates by 0.7%. Management said growth was driven by stronger U.S. procedure volumes, service revenue, consumables and expansion in its Healthcare and Life Sciences segments. The company also cited improved performance in capital equipment, though inflation, tariffs and severe winter weather weighed on procedural volumes and service activity, particularly in its Applied Sterilization Technologies business. Steris said it expects mid- to high-single-digit organic growth over the coming year, supported by service and consumables demand, automation and AI-related workflow investments, and recent tuck-in acquisitions. Shares traded at $207.19 after the report, up from $201.85 before the earnings release.